| 0.036 Data as of 3:57pm ET |  +0.0006 / +1.69%Today’s Change | 0.02 Today|||52-Week Range 0.10 | +44.00% Year-to-Date |
| Previous close | 0.04 |
| Today’s open | 0.04 |
| Day’s range | 0.04 - 0.04 |
| Volume | 676,090 |
| Average volume (3 months) | 2,864,259 |
| Market cap | $18.8M |
| Dividend yield | -- |
| Earnings growth (last year) | +62.50% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -90.18% |
| P/E ratio | NM |
| Price/Sales | 1,078.74 |
| Price/Book | -- |
| No competitors data available. |
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $28.7K |
| Annual profit (last year) | -$9.5M |
| Net profit margin | -33,123.72% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, CEO, Director & General Counsel Mark A. Fletcher |
Chief Operating Officer & Secretary David Brusegard, PhD |
Corporate headquarters Toronto, Ontario |
.
